Please Wait...

Margaret Ziola

Main profile

Margaret Ziola, MD
Medical Director, Cardiology and Neurovascular

In her position as Medical Director, Cardiology and Neurovascular at Synarc, she is responsible for the scientific oversight of all cardiovascular projects including coordination and collaboration with key opinion leaders and expert readers as well as our Sponsor's scientific counterparts. Dr. Ziola participates in clinical trial protocol design and data interpretation and regulatory strategy planning. She oversees the quality of Synarc's cardiology and neurovascular reading services and explores new applications of imaging to clinical trial research.

Dr. Ziola has more than twenty years of cardiovascular experience in support of pharmaceutical research and development programs. Her expertise includes clinical analysis, interpretation, and reporting of cardiac safety data for over 100 clinical trials in various therapeutic indications, including cardiovascular, infectious disease, oncology, CNS, gastroenterology, and endocrinology.

Dr. Ziola holds her medical degree from the Nicolaus Copernicus Jagiellonian University Medical School in Krakow, Poland. She has participated in expert meetings, given invited lectures and co-authored several scientific articles.

Prior to joining Synarc, Dr. Ziola worked at ARYx Therapeutics leading global cardiovascular clinical trials design, conduct and monitoring. Earlier in her career, she served as Director of Cardiovascular Clinical Services position at Gentiae Clinical Research, a cardiovascular core lab she helped establish, supporting central reading of cardiac imaging and electrocardiography. Prior to that she was affiliated with the groundbreaking Ischemia Research and Education Foundation.

Blogs

Part 1 of 2 It was both a great learning experience and fun to participate in another user conference, BioClinica's fifth and my third since joining the company in 2013. We spent quality time with both long-time collaborators and first-time partners.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (Yesterday)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (Yesterday)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (3 days ago)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (1 week ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (1 week ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (1 week ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen